| Literature DB >> 25927845 |
Kerry K W Cheung1, Ian C K Wong2, Patrick Ip3, Phyllis K L Chan4, Candy H Y Lin5, Lisa Y L Wong6, Esther W Chan7.
Abstract
BACKGROUND: Specialist services for the treatment of attention deficit hyperactivity disorder (ADHD) in adulthood in Hong Kong are yet to be developed. This study aims to explore the experiences of adolescents and young adults with ADHD in accessing treatment and services, coping with ADHD-related impairment, and their expectations of future treatment in Hong Kong.Entities:
Mesh:
Year: 2015 PMID: 25927845 PMCID: PMC4459071 DOI: 10.1186/s12888-015-0478-x
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Characteristics of participants
|
|
| |
|---|---|---|
|
|
| |
|
| ||
| Male | 13 (65) | 14 (70) |
| Female | 7 (35) | 6 (30) |
|
| ||
| 16 | 13 (65) | - |
| 17 | 7 (35) | - |
| 18 | - | 11 (55) |
| 19 | - | 5 (25) |
| 20-21 | - | 2 (10) |
| 22-23 | - | 2 (10) |
|
| ||
| Chinese | 18 (90) | 19 (95) |
| Other Asian | 0 (0) | 0 (0) |
| Other mixed | 1 (5) | 0 (0) |
| Non-Asian | 0 (0) | 0 (0) |
| Other | 1 (5) | 1 (5) |
|
| ||
| Student | 20 (100) | 15 (75) |
| Full-time job | 0 (0) | 4 (20) |
| Part-time job | 0 (0) | 1 (5) |
| Unemployed | 0 (0) | 0 (0) |
|
| ||
| Live alone | 0 (0) | (0) |
| Live with parents | 20 (100) | 19 (95) |
| Live with spouse | 0 (0) | 0 (0) |
| Live with children | 0 (0) | 0 (0) |
| Other | 0 (0) | 1 (5) |
|
| ||
| Junior high school (F.1-F.3) | 5 (25) | 3 (15) |
| High school (F.4-F.7) | 15 (75) | 11 (55) |
| Associate degree/high diploma | 0 (0) | 1 (5) |
| Bachelor degree | 0 (0) | 5 (25) |
Medical and treatment characteristics
|
|
| |
|---|---|---|
|
|
| |
|
| ||
| Childhood | 20 (100) | 15 (75) |
| Late adolescence/adulthood | - | 5 (25) |
|
| ||
| No treatment | 10 (48) | 12 (50) |
| ADHD training/behavioural therapy | 8 (38) | 10 (42) |
| Psychological counselling | 2 (10) | 1 (4) |
| Both treatments | 1 (5) | 1 (4) |
|
| ||
| Using medication | 17 (85) | 16 (80) |
| Discontinued medication* | 3 (15) | 4 (20) |
|
| ||
| Methylphenidate | 19 (95) | 18 (90) |
| Atomoxetine | 1 (5) | 1 (5) |
| Clonidine | 0 (0) | 1 (5) |
|
| ||
| 1-2 years | 0 (0) | 1 (5) |
| 3-4 years | 2 (10) | 2 (10) |
| 5+ years | 11 (55) | 9 (45) |
| 10-14 years | 7 (35) | 7 (35) |
| 15+ years | 0 (0) | 1 (5) |
|
| ||
| Less than 1 year | 2 (11) | 0 (0) |
| 1-2 years | 5 (26) | 3 (17) |
| 3-4 years | 1 (5) | 4 (22) |
| 5-9 years | 7 (37) | 7 (39) |
| 10-14 years | 4 (21) | 4 (22) |
*Discontinued for a period of 6 months or longer.
**Current or most recent medication.
***Missing data for 3 participants.
Figure 1Patients’ self-reported problems regarding ADHD treatment service in Hong Kong.